ES2773148T3 - Derivados aminofosfínicos para la prevención y el tratamiento de los dolores oculares - Google Patents

Derivados aminofosfínicos para la prevención y el tratamiento de los dolores oculares Download PDF

Info

Publication number
ES2773148T3
ES2773148T3 ES16809676T ES16809676T ES2773148T3 ES 2773148 T3 ES2773148 T3 ES 2773148T3 ES 16809676 T ES16809676 T ES 16809676T ES 16809676 T ES16809676 T ES 16809676T ES 2773148 T3 ES2773148 T3 ES 2773148T3
Authority
ES
Spain
Prior art keywords
group
compound
ethyl
atoms
phosphinoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16809676T
Other languages
English (en)
Spanish (es)
Inventor
Hervé Poras
Michel Wurm
Parsadaniantz Stéphane Melik
Goazigo Annabelle Reaux-Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaleads SA
Original Assignee
Pharmaleads SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaleads SA filed Critical Pharmaleads SA
Application granted granted Critical
Publication of ES2773148T3 publication Critical patent/ES2773148T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Biochemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES16809676T 2015-11-30 2016-11-30 Derivados aminofosfínicos para la prevención y el tratamiento de los dolores oculares Active ES2773148T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1561598A FR3044227B1 (fr) 2015-11-30 2015-11-30 Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires
PCT/EP2016/079285 WO2017093322A1 (fr) 2015-11-30 2016-11-30 Dérivés aminophosphiniques pour la prévention et le traitement des douleurs oculaires

Publications (1)

Publication Number Publication Date
ES2773148T3 true ES2773148T3 (es) 2020-07-09

Family

ID=55346018

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16809676T Active ES2773148T3 (es) 2015-11-30 2016-11-30 Derivados aminofosfínicos para la prevención y el tratamiento de los dolores oculares

Country Status (15)

Country Link
US (2) US20180344753A1 (enExample)
EP (1) EP3383403B1 (enExample)
JP (1) JP6889176B2 (enExample)
KR (1) KR102657652B1 (enExample)
CN (2) CN108289901B (enExample)
BR (1) BR112018010007A2 (enExample)
CA (1) CA3006365A1 (enExample)
DK (1) DK3383403T3 (enExample)
ES (1) ES2773148T3 (enExample)
FR (1) FR3044227B1 (enExample)
IL (1) IL259562B (enExample)
MX (1) MX382921B (enExample)
TW (1) TWI729039B (enExample)
WO (1) WO2017093322A1 (enExample)
ZA (1) ZA201804037B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
CN110352060A (zh) * 2017-03-09 2019-10-18 领先药物公司 用于预防和治疗眼部炎症的氨基次膦酸衍生物
FR3063635B1 (fr) * 2017-03-09 2019-06-07 Pharmaleads Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire
FR3104581B1 (fr) * 2019-12-11 2021-11-26 Pharmaleads Procédé de préparation industrielle du sel disodique de ((2S)-3-([1,1'-biphenyl]-4-yl)-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl) methyl)propanoyl)-L-alanine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0987291A (ja) * 1995-09-26 1997-03-31 Wakamoto Pharmaceut Co Ltd 新規なアラニン誘導体
FR2755135B1 (fr) 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
JP2001506652A (ja) * 1996-12-16 2001-05-22 アルコン ラボラトリーズ，インコーポレイテッド 眼の痛みを治療するためのκオピオイド・アゴニストの局所使用
FR2777780B1 (fr) * 1998-04-22 2001-05-04 Inst Nat Sante Rech Med Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
FR2934267B1 (fr) * 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
FR2934627B1 (fr) 2008-07-29 2010-08-13 Paul Marie Bernard Dispositif de positionnement et de calage d'un garde corps escamotable sur plateforme support de banches
AU2014216273A1 (en) * 2013-02-13 2015-07-09 Novartis Ag Topical ocular analgesic agents

Also Published As

Publication number Publication date
HK1259181A1 (zh) 2019-11-29
KR20180095555A (ko) 2018-08-27
MX2018006580A (es) 2018-08-01
JP2018536714A (ja) 2018-12-13
JP6889176B2 (ja) 2021-06-18
US10688113B2 (en) 2020-06-23
DK3383403T3 (da) 2020-03-16
BR112018010007A2 (pt) 2018-11-21
TW201726146A (zh) 2017-08-01
KR102657652B1 (ko) 2024-04-15
US20180344753A1 (en) 2018-12-06
US20190167701A1 (en) 2019-06-06
MX382921B (es) 2025-03-13
IL259562B (en) 2020-08-31
IL259562A (en) 2018-07-31
EP3383403A1 (fr) 2018-10-10
CN112121008A (zh) 2020-12-25
WO2017093322A1 (fr) 2017-06-08
ZA201804037B (en) 2020-07-29
CA3006365A1 (fr) 2017-06-08
EP3383403B1 (fr) 2019-12-25
FR3044227A1 (fr) 2017-06-02
CN108289901A (zh) 2018-07-17
TWI729039B (zh) 2021-06-01
CN108289901B (zh) 2021-05-04
FR3044227B1 (fr) 2017-11-24

Similar Documents

Publication Publication Date Title
ES2235254T3 (es) Preparaciones farmaceuticas que comprenden sales de acido hialuronico con anestesicos locales.
ES2951202T3 (es) Método para aumentar la biodisponibilidad y/o prolongar la acción oftálmica de un fármaco
ES2204879T3 (es) Neuroprotector para el ojo de mamiferos mediante administracion de bloqueadores del canal de potasio.
ES2910374T3 (es) Formulaciones oftálmicas de cetirizina y procedimientos de uso
PT735868E (pt) Utilizacao de inibidores da ciclo-oxigenase nao esteroides para o fabrico de um medicamento para o tratamento da pressao intraocular elevada
BR112012033435B1 (pt) Solução oftálmica, seu uso e frasco de dose única ou multi-dose feito de polietileno de baixa densidade sem aditivos
ES2684752T3 (es) Suspensiones de nanopartículas que contienen polímeros de carboxivinilo
CN102548548A (zh) 用于医学和兽医学的眼科药物组合物
US10688113B2 (en) Methods of treating eye pain with aminophosphinic derivatives
ES2986830T3 (es) Métodos de tratamiento de afecciones oculares
PT98895A (pt) Processo de preparacao de composicoes farmaceuticas a base de agentes bloqueadores dos canais de calcio em particular diltiazem verapamil,fostedil e di-hidropiridinas
BR112021000240A2 (pt) Composições oftálmicas que contêm uma prostamida que libera óxido nítrico
BR112020008046A2 (pt) composições e métodos de uso para tratamento de inflamação anormal em glândulas secretoras perioculares ou na superfície ocular
CA2055434A1 (en) Paracetamol-based pharmaceutical composition
PT97061B (pt) Metodo para a utilizacao de tenidap como inibidor da activacao de colagenase e da actividade de mieloperoxidase
RU2508123C1 (ru) Фармацевтическая композиция для местного применения при лечении воспалительных заболеваний глаз и способ ее использования
WO2005056113A1 (es) Compuestos para el tratamiento de la sequedad de la superficie ocular provocada por la cirugia fotorrefractiva
JP7316938B2 (ja) 眼の炎症を予防及び治療するためのアミノホスフィン誘導体
HK40042434A (en) Aminophosphinic derivatives for preventing and treating eye pain
US20250114347A1 (en) Topical naltrexone as a treatment for dry eye
WO2024010765A1 (en) Compositions for treating 5-ht2 conditions and methods of using the same
WO2021015647A1 (ru) Глазные капли для лечения возрастной катаракты ядерного вида
CN107041890A (zh) Su6656在制备治疗疼痛药物方面的应用
HK40016589A (en) Aminophosphinic derivatives for preventing and treating ocular inflammation
HK40016589B (en) Aminophosphinic derivatives for preventing and treating ocular inflammation